Status:
COMPLETED
Role of PACAP in Nehprotic Syndrome
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsors:
Fund for Scientific Research, Flanders, Belgium
Conditions:
Nephrotic Syndrome
Eligibility:
All Genders
Up to 18 years
Brief Summary
This study will identify the role of PACAP (pituitary adenylate cyclase-activating polypeptide) deficiency in patients with nephrotic syndrome. PACAP is a neuropeptide that has a putative role as an i...
Eligibility Criteria
Inclusion
- New patient with nephrotic syndrome of patient during relapse of nephrotic syndrome
- Under 16 years old
- Treatment for nephrotic syndrome not yet started by first sample collection
Exclusion
- None
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT01411982
Start Date
September 1 2011
End Date
September 1 2014
Last Update
January 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatrics, UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000